Fever is a common symptom in clinical practice, often indicating an underlying infection or inflammation. Despite its ubiquity, its management can pose challenges due to the myriad of potential causes and the diversity of patient responses. This article aims to provide a comprehensive guide to managing fever in clinical practice.
Fever is not a disease but a physiological response to a variety of conditions, predominantly infection. The febrile response is a complex physiological process involving cytokines, prostaglandins, and the hypothalamic-pituitary-adrenal axis. Recognizing fever as a symptom rather than a disease can guide clinicians towards a more patient-specific approach in management.
Assessing a patient with fever begins with a detailed history and physical examination. The history should focus on the onset, duration, and pattern of the fever, associated symptoms, travel history, and exposure to infectious agents. Physical examination may reveal localized signs of infection or systemic signs of inflammation. Laboratory investigations, including complete blood count, blood cultures, and inflammatory markers, can aid in identifying the underlying cause.
Antipyretic therapy is not always necessary and should be tailored to the patient's comfort and underlying condition. Non-pharmacological methods such as tepid sponging and adequate hydration can be effective in managing discomfort associated with fever. Pharmacological interventions, including acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), can be used for symptom relief. However, the primary focus should be on treating the underlying cause of the fever.
Special considerations are necessary in certain populations, such as infants, elderly patients, and immunocompromised individuals. In these patients, fever may be the only sign of a serious underlying condition, necessitating prompt evaluation and treatment. Additionally, these patients may not mount a typical febrile response, making diagnosis and management more challenging.
Regular monitoring of the patient's temperature and response to treatment is crucial. Persistent or recurrent fever despite appropriate treatment may indicate a more serious underlying condition or a complication. Follow-up is essential to ensure resolution of the fever and to monitor for potential relapses or complications.
Managing fever in clinical practice requires a comprehensive understanding of its physiological basis, a systematic approach to diagnosis, and a patient-specific treatment strategy. Special considerations are necessary for certain populations, and regular monitoring and follow-up are crucial to ensure optimal patient outcomes. By adopting these strategies, clinicians can effectively manage fever and improve patient care.
1.
Depression risk higher among long-term breast cancer survivors than women without breast cancer history
2.
Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.
3.
Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer
4.
A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.
5.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
1.
Therapeutic Advances in RNA-Based Hematologic Therapies
2.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
3.
Developmental Changes in Pediatric Coagulation Networks
4.
Clinical Guidelines for Tumor Evolution Tracking Using Dynamic Molecular Profiling
5.
Seeing the Unseen: Examining Chancroid Through Images
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Understanding the Importance of Early Cancer Detection
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation